tiprankstipranks
Sino Biopharmaceutical Ltd (CH:SMZ1)
:SMZ1
Switzerland Market
SMZ1
Sino Biopharmaceutical
RESEARCH TOOLSreports

Sino Biopharmaceutical (SMZ1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SMZ1 Analyst Ratings

Strong Buy
3Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Sino
Biopharmaceutical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SMZ1 Stock 12 Month Forecast

Average Price Target

CHF0.91
Based on 3 Wall Street analysts offering 12 month price targets for Sino Biopharmaceutical in the last 3 months. The average price target is CHF0.91 with a high forecast of CHF1.13 and a low forecast of CHF0.67. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF1.13Average Price TargetCHF0.91Lowest Price TargetCHF0.67
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citic Securities Analyst forecast on CH:SMZ1
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
CHF0.93
Buy
―
Reiterated
06/25/26
UBS Analyst forecast on CH:SMZ1
Unknown Analyst
UBS
Not Ranked
UBS
CHF1.13
Buy
―
Reiterated
05/26/26
UBS Remains a Buy on Sino Biopharmaceutical (SBMFF)
DBS Analyst forecast on CH:SMZ1
Mark Kong CFA
DBS
DBS
CHF0.67
Buy
―
Initiated
05/20/26
Analysts' Top Healthcare Picks: United Therapeutics (UTHR), Sino Biopharmaceutical (SBMFF)
BOCOM International Holdings Company Analyst forecast on CH:SMZ1
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
CHF0.88→CHF0.79
Buy
―
Reiterated
03/30/26
BOCOM International Holdings Company Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
CMB International Securities Analyst forecast on CH:SMZ1
Jill Wu
CMB International Securities
CMB International Securities
CHF0.9
Buy
―
Reiterated
03/30/26
CMB International Securities Sticks to Their Buy Rating for Sino Biopharmaceutical (SBMFF)
Jefferies Analyst forecast on CH:SMZ1
Chu Wang
Jefferies
Jefferies
CHF0.72
Buy
―
Reiterated
03/30/26
Jefferies Reaffirms Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Bank of China Analyst forecast on CH:SMZ1
Unknown Analyst
Bank of China
Not Ranked
Bank of China
CHF0.82
Buy
―
Reiterated
03/27/26
Sino Biopharmaceutical (SBMFF) Gets a Buy from Bank of China
Citi Analyst forecast on CH:SMZ1
Unknown Analyst
Citi
Not Ranked
Citi
CHF1.03
Buy
―
Reiterated
03/27/26
Sino Biopharmaceutical (SBMFF) Gets a Buy from Citi
Bank of America Securities Analyst forecast on CH:SMZ1
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
CHF0.76
Buy
―
Reiterated
03/27/26
Bank of America Securities Sticks to Their Buy Rating for Sino Biopharmaceutical (SBMFF)
CICC Analyst forecast on CH:SMZ1
Unknown Analyst
CICC
Not Ranked
CICC
CHF0.92
Buy
―
Reiterated
03/27/26
CICC Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Nomura Analyst forecast on CH:SMZ1
Unknown Analyst
Nomura
Not Ranked
Nomura
CHF0.89
Buy
―
Reiterated
03/26/26
Nomura Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Bernstein Analyst forecast on CH:SMZ1
Rebecca Liang
Bernstein
Bernstein
CHF0.81
Hold
―
Reiterated
02/09/26
Bernstein Remains a Hold on Sino Biopharmaceutical (SBMFF)
Daiwa Analyst forecast on CH:SMZ1
Unknown Analyst
Daiwa
Not Ranked
Daiwa
CHF1.03
Buy
―
Reiterated
11/12/25
GF Securities Analyst forecast on CH:SMZ1
Unknown Analyst
GF Securities
Not Ranked
GF Securities
CHF1.19
Buy
―
Reiterated
10/14/25
HSBC Analyst forecast on CH:SMZ1
Linda Shu
HSBC
HSBC
CHF0.99
Buy
―
Reiterated
09/30/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citic Securities Analyst forecast on CH:SMZ1
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
CHF0.93
Buy
―
Reiterated
06/25/26
UBS Analyst forecast on CH:SMZ1
Unknown Analyst
UBS
Not Ranked
UBS
CHF1.13
Buy
―
Reiterated
05/26/26
UBS Remains a Buy on Sino Biopharmaceutical (SBMFF)
DBS Analyst forecast on CH:SMZ1
Mark Kong CFA
DBS
DBS
CHF0.67
Buy
―
Initiated
05/20/26
Analysts' Top Healthcare Picks: United Therapeutics (UTHR), Sino Biopharmaceutical (SBMFF)
BOCOM International Holdings Company Analyst forecast on CH:SMZ1
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
CHF0.88→CHF0.79
Buy
―
Reiterated
03/30/26
BOCOM International Holdings Company Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
CMB International Securities Analyst forecast on CH:SMZ1
Jill Wu
CMB International Securities
CMB International Securities
CHF0.9
Buy
―
Reiterated
03/30/26
CMB International Securities Sticks to Their Buy Rating for Sino Biopharmaceutical (SBMFF)
Jefferies Analyst forecast on CH:SMZ1
Chu Wang
Jefferies
Jefferies
CHF0.72
Buy
―
Reiterated
03/30/26
Jefferies Reaffirms Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Bank of China Analyst forecast on CH:SMZ1
Unknown Analyst
Bank of China
Not Ranked
Bank of China
CHF0.82
Buy
―
Reiterated
03/27/26
Sino Biopharmaceutical (SBMFF) Gets a Buy from Bank of China
Citi Analyst forecast on CH:SMZ1
Unknown Analyst
Citi
Not Ranked
Citi
CHF1.03
Buy
―
Reiterated
03/27/26
Sino Biopharmaceutical (SBMFF) Gets a Buy from Citi
Bank of America Securities Analyst forecast on CH:SMZ1
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
CHF0.76
Buy
―
Reiterated
03/27/26
Bank of America Securities Sticks to Their Buy Rating for Sino Biopharmaceutical (SBMFF)
CICC Analyst forecast on CH:SMZ1
Unknown Analyst
CICC
Not Ranked
CICC
CHF0.92
Buy
―
Reiterated
03/27/26
CICC Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Nomura Analyst forecast on CH:SMZ1
Unknown Analyst
Nomura
Not Ranked
Nomura
CHF0.89
Buy
―
Reiterated
03/26/26
Nomura Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Bernstein Analyst forecast on CH:SMZ1
Rebecca Liang
Bernstein
Bernstein
CHF0.81
Hold
―
Reiterated
02/09/26
Bernstein Remains a Hold on Sino Biopharmaceutical (SBMFF)
Daiwa Analyst forecast on CH:SMZ1
Unknown Analyst
Daiwa
Not Ranked
Daiwa
CHF1.03
Buy
―
Reiterated
11/12/25
GF Securities Analyst forecast on CH:SMZ1
Unknown Analyst
GF Securities
Not Ranked
GF Securities
CHF1.19
Buy
―
Reiterated
10/14/25
HSBC Analyst forecast on CH:SMZ1
Linda Shu
HSBC
HSBC
CHF0.99
Buy
―
Reiterated
09/30/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sino Biopharmaceutical

3 Months
Michael Luo CFACLSA
Success Rate
3/3 ratings generated profit
100%
Average Return
+46.43%
Copying Michael Luo CFA's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +46.43% per trade.
1 Year
Linda ShuHSBC
Success Rate
3/5 ratings generated profit
60%
Average Return
-1.66%
Copying Linda Shu's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -1.66% per trade.
2 Years
Linda ShuHSBC
Success Rate
3/5 ratings generated profit
60%
Average Return
+54.72%
Copying Linda Shu's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +54.72% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SMZ1 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
6
6
7
2
2
Buy
6
4
5
1
1
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
11
12
3
3
In the current month, SMZ1 has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SMZ1 average Analyst price target in the past 3 months is 0.91.
Each month's total comprises the sum of three months' worth of ratings.

SMZ1 Financial Forecast

SMZ1 Earnings Forecast

Next quarter’s earnings estimate for SMZ1 is CHF0.01 with a range of CHF0.01 to CHF0.01. The previous quarter’s EPS was <CHF0.01. SMZ1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for SMZ1 is CHF0.01 with a range of CHF0.01 to CHF0.01. The previous quarter’s EPS was <CHF0.01. SMZ1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.

SMZ1 Sales Forecast

Next quarter’s sales forecast for SMZ1 is CHF2.39B with a range of CHF2.39B to CHF2.39B. The previous quarter’s sales results were CHF1.61B. SMZ1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.
Next quarter’s sales forecast for SMZ1 is CHF2.39B with a range of CHF2.39B to CHF2.39B. The previous quarter’s sales results were CHF1.61B. SMZ1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.

SMZ1 Stock Forecast FAQ

What is CH:SMZ1’s average 12-month price target, according to analysts?
Based on analyst ratings, Sino Biopharmaceutical Ltd’s 12-month average price target is 0.91.
    What is CH:SMZ1’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:SMZ1, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Sino Biopharmaceutical Ltd a Buy, Sell or Hold?
        Sino Biopharmaceutical Ltd has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Sino Biopharmaceutical Ltd’s share price target?
          The average share price target for Sino Biopharmaceutical Ltd is 0.91. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF1.13 ,and the lowest forecast is CHF0.67. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Sino Biopharmaceutical Ltd?
            Sino Biopharmaceutical Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
              How can I buy shares of Sino Biopharmaceutical Ltd?
              To buy shares of CH:SMZ1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.